Eptifibatide Injection
Product Images NDC 0338-9558

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 0338-9558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eptifibatide Chemical Structure (Image 01)

Chemical structure of the active ingredient Eptifibatide, depicted as a molecular diagram showing its chemical bonds and components.*

FDA Label Image

Figure 1: Kaplan-meier Plot Of Time To Death Or Myocardial Infarction Within 30 Days Of Randomization In The Pursuit Study (Image 02)

A line graph comparing the percent of patients with events over 30 days between Eptifibatide treatment and placebo. The x-axis represents time in days (0 to 30), and the y-axis shows the percent of patients with events (0 to 16%). The solid line indicates Eptifibatide, and the dashed line indicates placebo, with placebo showing a higher percentage of events throughout the period.*

FDA Label Image

Representative Container Label Ndc 0338-9559-10 (Image 03)

Eptifibatide Injection 75 mg per 100 mL (0.75 mg/mL) intravenous injection supplied in a single-dose container by Baxter Healthcare Company. The label provides dosing details, storage instructions, and cautions, indicating the product is sterile, nonpyrogenic, and intended for intravenous infusion only, with a labeler address in Deerfield, IL, USA.*

FDA Label Image

Representative Carton Label 0338-9558-10 (Image 04)

Packaging label for Eptifibatide Injection 75 mg per 100 mL (0.75 mg/mL) intravenous infusion, labeled for use only by intravenous infusion and not intravenous bolus use. The label includes dosing and storage information, manufacturer details (Baxter Healthcare Company), and caution about not adding supplemental medication or additives. It also specifies carton use to protect from light until administration. The product NDC is 0338-9558-10.*

FDA Label Image

Representative Shipper Label For Serialization (Image 05)

Label for Eptifibatide Injection, 75 mg per 100 mL (0.75 mg/mL) intravenous injection by Baxter Healthcare Company. The label indicates storage instructions, packaging in 12 x 100 mL single-dose containers, and the NDC 0338-9558-10. It also specifies prescription use only and includes the Baxter logo.*

FDA Label Image

Representative Shipper Label For Serialization Panel 2 Of 2 (Image 06)

Eptifibatide Injection 75 mg per 100 mL (0.75 mg/mL) packaging label from Baxter Healthcare Company. Contains 12 x 100 mL GALAXY Single-Dose Containers. The label includes storage instructions and the product NDC 0338-9558-10.*

FDA Label Image

Representative Container Label Ndc 0338-9559-20 (Image 07)

Label for Eptifibatide Injection 200 mg per 100 mL (2 mg/mL) sterile intravenous solution by Baxter Healthcare Company. The label indicates it is a single-dose container for intravenous infusion only, not for bolus use, with storage instructions and cautions. The NDC is 0338-9559-20.*

FDA Label Image

Representative Carton Label 0338-9559-20 (Image 08)

Eptifibatide Injection 200 mg per 100 mL (2 mg/mL) intravenous infusion solution packaging label from Baxter Healthcare Company. The label includes dosage concentration, storage instructions, and usage warnings, specifying it is for intravenous infusion only and not for intravenous bolus use. The product is a single-dose container with instructions to discard unused portions.*

FDA Label Image

Representative Shipper Label 0338-9559-20 For Serialization Panel 1 Of 2 (Image 09)

Eptifibatide Injection 200 mg per 100 mL (2 mg/mL) intravenous injection label. Contains 12 single-dose containers of 100 mL each. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA. Storage instructions include refrigeration at 2-8°C and transfer to controlled room temperature for up to 2 months, with discard instructions if unused after transfer.*

FDA Label Image

Representative Shipper Label For Serialization 0338-9559-20 Panel 2 Of 2 (Image 10)

Label for Eptifibatide Injection 200 mg per 100 mL (2 mg/mL) intravenous injection by Baxter Healthcare Company. The label states it contains 12 single-dose 100 mL containers, with storage instructions for refrigeration and controlled room temperature. NDC 0338-9559-20 is visible; the label also includes the Baxter logo and prescription-only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.